(Q51034694)

English

TGF-β engineered mesenchymal stem cells (TGF-β/MSCs) for treatment of Type 1 diabetes (T1D) mice model.

scientific article published on 19 January 2017

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28110219

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/28110219

title

TGF-β engineered mesenchymal stem cells (TGF-β/MSCs) for treatment of Type 1 diabetes (T1D) mice model. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28110219

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/28110219

1 reference

mesenchymal stem cell

1 reference

Saeed Daneshmandi

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28110219

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/28110219

Mohammad Hossein Karimi

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28110219

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/28110219

Ali Akbar Pourfathollah

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28110219

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/28110219

publication date

19 January 2017

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28110219

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/28110219

published in

International Immunopharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28110219

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/28110219

volume

44

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28110219

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/28110219

page(s)

191-196

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28110219

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/28110219

Identifiers

DOI

10.1016/J.INTIMP.2017.01.019

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28110219

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/28110219

PubMed publication ID

28110219

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28110219

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/28110219

(Q51034694)

TGF-β engineered mesenchymal stem cells (TGF-β/MSCs) for treatment of Type 1 diabetes (T1D) mice model.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)